0001562180-24-000605.txt : 20240125 0001562180-24-000605.hdr.sgml : 20240125 20240125160140 ACCESSION NUMBER: 0001562180-24-000605 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240124 FILED AS OF DATE: 20240125 DATE AS OF CHANGE: 20240125 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LaCascia Michael CENTRAL INDEX KEY: 0001831755 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39634 FILM NUMBER: 24562138 MAIL ADDRESS: STREET 1: 500 TECHNOLOGY SQUARE STREET 2: SUITE 700 CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Foghorn Therapeutics Inc. CENTRAL INDEX KEY: 0001822462 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 TECHNOLOGY SQUARE STREET 2: SUITE 700 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-586-3100 MAIL ADDRESS: STREET 1: 500 TECHNOLOGY SQUARE STREET 2: SUITE 700 CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 primarydocument.xml PRIMARY DOCUMENT X0508 4 2024-01-24 false 0001822462 Foghorn Therapeutics Inc. FHTX 0001831755 LaCascia Michael 500 TECHNOLOGY SQUARE STE 700 CAMBRIDGE MA 02139 false true false false Chief Legal Officer false Stock Option (right to buy) 3.06 2024-01-24 4 A false 100000.00 3.06 A 2034-01-23 Common Stock 100000.00 100000.00 D The option vests as to 25% of the underlying shares of common stock on January 24, 2025, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter. /s /Tara Maduri, Attorney-in-Fact for Michael LaCascia 2024-01-25